Skip to main content
. 2020 Dec 10;32(5):817–829. doi: 10.1007/s00198-020-05756-8

Fig. 2.

Fig. 2

Criteria for initiation of pharmacological treatment for osteoporosis in Japan (adapted from Orimo et al. [39]). Abbreviations: aBMD: bone mineral density, YAM: young adult mean for women; FRAX: fracture risk assessment tool FRAX® (www.shef.ac.uk/FRAX). 1 proximal femur (hip) fracture and/or vertebral fracture caused by a slight external force after menopause in women and after age 50 in men. 2 distal forearm, proximal humerus, pelvis, lower leg, and/or rib fracture caused by a slight external force after menopause in women and after age 50 in men. 3 revision of additional T-scores is under consideration for some measurement sites. An aBMD less than 70% of YAM is equivalent to DXA T-score of − 2.5. 4 applied in persons < 75 years. Additionally, a lower cut-off value does not include all young persons in and around their 50s for whom pharmacological treatment is recommended based on the present diagnostic criteria. 5 critera should be applied only to persons who answer “No” to FRAX® risk factors of “glucocorticoid,” “rheumatoid arthritis,” or “secondary osteoporosis”